Iniparib Phase III study in metastatic triple-negative breast cancer does not meet pr - HER2 Support Group Forums

		HER2 Support Group Forums > General Cancer News
Iniparib Phase III study in metastatic triple-negative breast cancer does not meet pr

General Cancer News Latest Breast Cancer News from Moreover Technologies

Reply

01-27-2011, 10:30 PM	#1
News Senior Member Join Date: Oct 2007 Posts: 18,983	Iniparib Phase III study in metastatic triple-negative breast cancer does not meet pr Sanofi-aventis and its subsidiary, BiPar Sciences, today announced that a randomized Phase III trial evaluating iniparib (BSI-201) in patients with metastatic triple-negative breast cancer (mTNBC) did not meet the pre-specified criteria for significance for co-primary endpoints of overall survival and progression-free survival More...

Reply

« Previous Thread | Next Thread »

Posting Rules
You may not post new threads You may not post replies You may not post attachments You may not edit your posts BB code is On Smilies are On [IMG] code is On HTML code is Off Forum Rules

All times are GMT -7. The time now is 06:34 PM.

free webpage hit counter